Gilead Sciences Inc at Cowen Health Care Conference Transcript

Mar 07, 2023 / 04:10PM GMT
Tyler Martin Van Buren - TD Cowen, Research Division - MD & Senior Equity Research Analyst

Good morning, everyone. Is this slide over? Is there an interference from the speaker? I guess it's just loud.

All right. Well, again, good morning. Tyler Van Buren here, senior biotech analyst at TD Cowen. Thanks again for coming to TD Cowen's 43rd Annual Healthcare Conference. For our next session, we're privileged to have a fireside chat with Gilead. And from Gilead, we have Andy Dickinson, the Chief Financial Officer. Andy, thank you very much for being here.

Andrew D. Dickinson - Gilead Sciences, Inc. - Executive VP & CFO

Thank you. We're thrilled to be here. I appreciate you having us.

Questions and Answers:

Tyler Martin Van Buren - TD Cowen, Research Division - MD & Senior Equity Research Analyst

Of course. And if you guys have any questions, feel free to raise your hand, and we'll do our best to get it asked.

So for an opening question, Andy, maybe you could just start with the
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot